Moderna Stock Skids After 2023 Guidance Misses By More Than $2 Billion – Investor’s Business Daily

by

  1. Moderna Stock Skids After 2023 Guidance Misses By More Than $2 Billion Investor’s Business Daily
  2. Moderna misses on earnings as costs rise from surplus production capacity, lower Covid shot demand CNBC
  3. Sliding vaccine sales, new costs, shrink Moderna 4Q profit Yahoo Finance
  4. Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio Yahoo Finance
  5. Moderna earnings fall short of estimates amid steep decline in COVID vaccine sales, expects to file for approval of RSV vaccine in first half MarketWatch
  6. View Full Coverage on Google News

Read original article here

Leave a Comment